Physician
Nuclear Medicine
Dr. Daniel A. Pryma, MD
|
|
Give Review
Daniel Pryma is an expert in the field of Nuclear Medicine. He went to Loyola University Chicago Stritch School of Medicine. He over the years received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Daniel A. Pryma has written publications. He has 37 publications published with PubMed. The lastest paper is: 'The contribution of physics to Nuclear Medicine: physicians' perspective on future directions.' He accepts all Medicare patients.
Publications
- A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688.
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.
- Use of Standardized Uptake Value Ratios Decreases Interreader Variability of [18F] Florbetapir PET Brain Scan Interpretation.
- The contribution of physics to Nuclear Medicine: physicians' perspective on future directions.
- Radioiodine Therapy for Thyroid Cancer in the Era of Risk Stratification and Alternative Targeted Therapies.
- Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer.
- PET/CT imaging in cancer: Current applications and future directions.
- Molecular Imaging Biomarkers for Oncology Clinical Trials.
- Stage Migration in Planning PET/CT Scans in Patients Due to Receive Radiotherapy for Non-Small-Cell Lung Cancer.
- The nuclear receptor Rev-erbα controls circadian thermogenic plasticity.
- Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide.
- A review of contemporary data on surgically resected renal masses--benign or malignant?
- Impact of PET Staging in Limited-Stage Small-Cell Lung Cancer.
- Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response.
- Evaluating the Impact of New Imaging Tests: Promises and Pitfalls.
- A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer: A Report of Tox...
- 124I-huA33 Antibody Uptake Is Driven by A33 Antigen Concentration in Tissues from Colorectal Cancer Patients Imaged by Immuno-PET.
- 124I-huA33 Antibody PET of Colorectal Cancer.
- Correlation of in vivo and in vitro measures of carbonic anhydrase IX antigen expression in renal masses using antibody 124I-cG250.
- Sestamibi SPECT intensity scoring system in sporadic primary hyperparathyroidism.
- Localization of parathyroid adenomas by sonography and technetium tc 99m sestamibi single-photon emission computed tomography before minimally invasive parathyroidecto...
- Parathyroid imaging.
- Drainage characteristics and differential function of the horseshoe kidney: what is typical?
- Can a lightbulb sestamibi SPECT accurately predict single-gland disease in sporadic primary hyperparathyroidism?
- Acute intramural hematoma of the aorta as a cause of positive FDG PET/CT.
- Acute intramural hematoma of the aorta as a cause of positive fluorodeoxyglucose positron emission tomography/computed tomography.
- I-123 MIBG scan of metastatic neuroblastoma mimicking a bone scan.
- Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients.
- Hydronephrotic ectopic pelvic kidney simulates sacral metastasis from breast cancer.
- Cardiovascular risk assessment in cancer patients undergoing major surgery.
- Clinical utility of integrated positron emission tomography/computed tomography imaging in the clinical management and radiation treatment planning of locally advanced...
- Predicting Outcomes in Locally-Advanced Rectal Cancer Using Pretreatment FDG-PET Imaging.
- A Pilot Study of F18 EF5 PET/CT Imaging in Patients With Carcinoma of the Cervix.
- Distribution and partial characterization of CREB-like immunoreactivity in the medicinal leech Hirudo.
- Molecular imaging of renal cell carcinoma.
- Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phas...
Schools
Loyola University of Chicago Stritch School of Medicine
Doctors Specialties
- Nuclear Medicine
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Memorial Sloan-Kettering Cancer Center -
Loyola University -
Loyola University Chicago Stritch School of Medicine
Hospital
-
Philadelphia Veterans Affairs Medical Center -
Hospital of the University of Pennsylvania -
Pennsylvania Hospital -
Penn Presbyterian Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1366417818 |
| Last Name Of The Provider | PRYMA |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
|
Dr. Samar J. Hajj, MD |
|
|
Manoranjana Chawla
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan M. Burke, MD |
|
|
Dr. Syed M. Mahmood, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phyllisann K. Dioguardi, MD |
|
|
Dr. Arnold Berkowitz, MD |
|
|
Dr. Thomas L. Carter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jian Q. Yu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Antoniades, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Noel L. Melhorn, DO
This Doctor is OpenDoctor Recommended.
|